LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LNSR is expected to report earnings to fall 139.60% to -3 cents per share on March 09
Q4'26
Est.
$-0.04
Q2'26
Beat
by $0.31
Q1'26
Missed
by $0.18
Q4'25
Missed
by $0.05
Q3'25
Missed
by $0.26
The last earnings report on August 13 showed earnings per share of 10 cents, beating the estimate of -20 cents. With 143.61K shares outstanding, the current market capitalization sits at 73.96M.